Abstract:Key PointsCRISPR–Cas (clustered regularly interspaced short palindromic repeats–CRISPR-associated proteins) is an adaptive immune system in bacteria and archaea, which is categorized into three distinct types (known as type I, type II and type III) that differ in their compositions and mechanisms of action. Adaptive immunity occurs in three distinct stages: acquisition, expression and interference.In all three types of CRISPR–Cas system, spacer acquisition relies on a pair of conserved Cas proteins (Cas1 and Cas2), which are probably assisted by a variable set of additional (potentially both Cas and non-Cas) enzymes.Primary processing of CRISPR RNAs (crRNAs) is catalysed either by Cas6-like ribonucleases (in the type I and type III systems) or by RNase III (which targets the crRNA and transactivating crRNA (tracrRNA) duplex in type II systems).Mature crRNAs form CRISPR ribonucleoprotein (crRNP) complexes by associating with either Cascade-like multiprotein complexes (in type I and type III systems) or the multidomain Cas9 protein (in type II systems).Discrimination of 'self' nucleic acid from 'non-self' nucleic acid enables crRNP complexes to specifically target invading nucleic acid (usually DNA). Some complexes recruit additional nucleases (for example, Cas3 in type I systems), whereas other crRNPs have intrinsic nuclease domains (for example, Cas9 in type II systems).Fundamental studies have elucidated many mechanistic features of CRISPR–Cas functionality by integrating genetics, biochemistry and structural biology. This has provided an excellent basis for developing a wide range of applications, from the manipulation of gene expression in bacteria to genome editing in eukaryotes.

The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems

A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems

Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence

Multistep Intersystem Crossing Pathways in Cinnamate-Based UV-B Sunscreens.

Molecular Mechanisms Of Iii-B Crispr-Cas Systems In Archaea

Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

Type III CRISPR-Cas System: Introduction and Its Application for Genetic Manipulations.

Bioinformatic analysis of type III CRISPR systems reveals key properties and new effector families

Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate

Diversity and abundance of ring nucleases in type III CRISPR-Cas loci

Type III-B CRISPR-Cas cascade of proteolytic cleavages

Structural and functional insights into the type III-E CRISPR-Cas immunity

Antiviral type III CRISPR signalling via conjugation of ATP and SAM

Nanopores Reveal the Stoichiometry of Single Oligoadenylates Produced by Type III CRISPR-Cas

Inhibition of Type III CRISPR-Cas Immunity by an Archaeal Virus-Encoded Anti-CRISPR Protein

A Membrane-Associated DHH-DHHA1 Nuclease Degrades Type III CRISPR Second Messenger

Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR–Cas that degrades the second messenger cA4

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Cyclic Nucleotide Signaling in Phage Defense and Counter-Defense

A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator